Format

Send to:

Choose Destination
See comment in PubMed Commons below
Oncology (Williston Park). 1988 Feb;2(2):33-41.

The carcinoid syndrome: a treatable malignant disease.

Author information

  • 1Department of Oncology, Mayo Comprehensive Cancer Center, Rochester, MN 55905.

Abstract

In the carcinoid syndrome, surgery is often curative when the disease is detected early and it may also provide palliation for some patients with metastatic disease. Often metastatic disease requires no treatment for months or years unless symptoms are serious or troublesome. Chemotherapy with either doxorubicin alone or streptozocin plus 5-FU achieves a response rate of about 23-33%. Hepatic artery occlusion followed by sequential chemotherapy has produced striking relief of symptoms, a higher percentage of regressions, and a longer duration of response. Somatostatin 201-995 is very effective in treating the syndrome and in preventing carcinoid crisis and has the advantage of producing virtually no significant side effects.

PMID:
3079320
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk